BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1058 related articles for article (PubMed ID: 19421076)

  • 1. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).
    Wassertheil-Smoller S; Shumaker S; Ockene J; Talavera GA; Greenland P; Cochrane B; Robbins J; Aragaki A; Dunbar-Jacob J
    Arch Intern Med; 2004 Feb; 164(3):289-98. PubMed ID: 14769624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
    Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
    Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation.
    Thurston RC; Sowers MR; Chang Y; Sternfeld B; Gold EB; Johnston JM; Matthews KA
    Am J Epidemiol; 2008 Jan; 167(1):78-85. PubMed ID: 17881385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of hot flashes and night sweats.
    Sievert LL; Obermeyer CM; Price K
    Ann Hum Biol; 2006; 33(1):4-16. PubMed ID: 16500807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity and risk of hot flashes among women in midlife.
    Whitcomb BW; Whiteman MK; Langenberg P; Flaws JA; Romani WA
    J Womens Health (Larchmt); 2007; 16(1):124-33. PubMed ID: 17324103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasomotor symptoms and cardiovascular disease risk.
    Pines A
    Climacteric; 2011 Oct; 14(5):535-6. PubMed ID: 21848496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study.
    Smoller JW; Pollack MH; Wassertheil-Smoller S; Jackson RD; Oberman A; Wong ND; Sheps D
    Arch Gen Psychiatry; 2007 Oct; 64(10):1153-60. PubMed ID: 17909127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent hot flushes in older postmenopausal women.
    Huang AJ; Grady D; Jacoby VL; Blackwell TL; Bauer DC; Sawaya GF
    Arch Intern Med; 2008 Apr; 168(8):840-6. PubMed ID: 18443259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study.
    Herber-Gast G; Brown WJ; Mishra GD
    BJOG; 2015 Oct; 122(11):1560-7. PubMed ID: 25377022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms reported by women in midlife: menopausal transition or aging?
    Berecki-Gisolf J; Begum N; Dobson AJ
    Menopause; 2009; 16(5):1021-9. PubMed ID: 19546824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasomotor symptoms are associated with a lower bone mineral density.
    Gast GC; Grobbee DE; Pop VJ; Keyzer JJ; Wijnands-van Gent CJ; Samsioe GN; Nilsson PM; van der Schouw YT
    Menopause; 2009; 16(2):231-8. PubMed ID: 19034053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms.
    Gast GC; Pop VJ; Samsioe GN; Grobbee DE; Nilsson PM; Keyzer JJ; Wijnands-van Gent CJ; van der Schouw YT
    Maturitas; 2011 Dec; 70(4):373-8. PubMed ID: 21978631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Average blood pressure and cardiovascular disease-related mortality in middle-aged women.
    van Trijp MJ; Grobbee DE; Peeters PH; van Der Schouw YT; Bots ML
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):197-201. PubMed ID: 15752947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking, estrogen levels, and hot flashes in midlife women.
    Gallicchio L; Miller SR; Visvanathan K; Lewis LM; Babus J; Zacur H; Flaws JA
    Maturitas; 2006 Jan; 53(2):133-43. PubMed ID: 16368467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived control, lifestyle, health, socio-demographic factors and menopause: impact on hot flashes and night sweats.
    Pimenta F; Leal I; Maroco J; Ramos C
    Maturitas; 2011 Aug; 69(4):338-42. PubMed ID: 21680119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.